Omeprazole
Back to searchMolecule Structure
Scientific Name
Omeprazole
Description of the Drug
Omeprazole is a proton pump inhibitor used to treat GERD associated conditions such as heartburn and gastric acid hypersecretion, and to promote healing of tissue damage and ulcers caused by gastric acid and H. pylori infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00338
http://www.drugbank.ca/drugs/DB00338
Brand Name(s)
Antra, Losec, Losec mups, Mezzopram, Mopral, Omeprazole, Omeran, Prilosec, Zanprol
Company Owner(s)
Redhill Biopharma Ltd, Riley Consumer Care Llc Dba Carlin Consumer Health, Mylan Pharmaceuticals Inc, Impax Laboratories Inc, Aurolife Pharma Llc, Zydus Pharmaceuticals Usa Inc, Perrigo R And D Co, Breckenridge Pharmaceutical Inc, Ajanta Pharma Ltd, Sun Pharma Industries Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Potassium-transporting ATPase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2095173 |
Clinical Trial(s)
Unichem Links
| Atlas | omeprazole | |||
| SureChEMBL | SCHEMBL1191 | |||
| PharmGKB | PA10075 | PA450704 | ||
| Human Metabolome Database | HMDB0001913 | |||
| DrugBank | DB00338 | |||
| PubChem: Thomson Pharma | 14753960 | 14875946 | ||
| PubChem | 4594 | |||
| Mcule | MCULE-3224208952 | |||
| NMRShiftDB | 20032654 | 10018799 | ||
| LINCS | LSM-1651 | |||
| Nikkaji | J33.884B | |||
| BindingDB | 50241343 | |||
| EPA CompTox Dashboard | DTXSID6021080 | |||
| DrugCentral | 1990 | |||
| Brenda | 14574 | 2976 | ||
| ChemicalBook | CB8160492 | CB5160491 | CB6740618 | |
| Guide to Pharmacology | 4279 | |||
| rxnorm | OMEPRAZOLE | OMEPRAZOLE MAGNESIUM | PRILOSEC | OMEPRAZOLE SODIUM |
| PubChem: Drugs of the Future | 12013167 | |||
| KEGG Ligand | C07324 | |||
| ChEBI | 91766 | 77260 |
